SCHEMBL14005455

SCHEMBL14005455

CC/C(=C/F)CCc1ccc(F)cc1

nearest known ligand 0.69

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
AOC3 Q16853 2/20 0.69
AOC2 O75106 2/20 0.69
MAOA P21397 2/20 0.69
MAOB P27338 2/20 0.69
HPGD P15428 1/20 0.42
TAAR1 Q96RJ0 3/20 0.41
FFAR1 O14842 1/20 0.41
PTGS1 P23219 1/20 0.41
PTGS2 P35354 1/20 0.41
SLC5A1 P13866 1/20 0.39
SLC5A2 P31639 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
DAO P14920 1/20 0.38
TRPA1 O75762 1/20 0.37
PLAAT3 P53816 1/20 0.36
PLAAT5 Q96KN8 1/20 0.36
PLAAT2 Q9NWW9 1/20 0.36
PLAAT4 Q9UL19 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7322207 0.83 MAOB (0.71) AOC3AOC2MAOAMAOBTAAR1
SCHEMBL7322216 0.83 MAOB (0.71) AOC3AOC2MAOAMAOBTAAR1
SCHEMBL8585089 0.81 MAOB (0.69) AOC3AOC2MAOAMAOBTAAR1
Mofegiline SCHEMBL147813 0.81 MAOB (1.00) AOC3AOC2MAOAMAOBTAAR1
SCHEMBL8585905 0.81 AOC2 (0.69) AOC3AOC2MAOAMAOBHPGD
Mofegiline SCHEMBL14005358 0.81 MAOB (1.00) AOC3AOC2MAOAMAOBTAAR1
Mofegiline SCHEMBL1295043 0.81 MAOB (1.00) AOC3AOC2MAOAMAOBTAAR1
SCHEMBL8585084 0.81 MAOB (0.69) AOC3AOC2MAOAMAOBTAAR1
SCHEMBL8585907 0.81 AOC2 (0.69) AOC3AOC2MAOAMAOBHPGD
Mofegiline SCHEMBL1295041 0.81 MAOB (1.00) AOC3AOC2MAOAMAOBTAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080292547-A1 Novel Imaging Agents for Fibrosis TOLLESHAUG HELGE 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080292547-A1 Novel Imaging Agents for Fibrosis LOXL1, LOXL2, LOXL3 AOC3 366/4885AOC2 468/4885MAOA 1033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.